000			02324 a2200589 4500
005			20250514021643.0
264		0	_c20020617
008			200206s 0 0 eng d
022			_a1084-9785
024	7		_a10.1089/108497801753354267 _2doi
040			_aNLM _beng _cNLM
100	1		_aSolorzano, C C
245	0	0	_aInhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. _h[electronic resource]
260			_bCancer biotherapy & radiopharmaceuticals _cOct 2001
300			_a359-70 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma _xblood supply
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aIn Situ Nick-End Labeling
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Proteins _xanalysis
650	0	4	_aNeoplasm Transplantation
650	0	4	_aPancreatic Neoplasms _xblood supply
650	0	4	_aPhthalazines _xadministration & dosage
650	0	4	_aPlatelet Endothelial Cell Adhesion Molecule-1 _xanalysis
650	0	4	_aProliferating Cell Nuclear Antigen _xanalysis
650	0	4	_aPyridines
650	0	4	_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aReceptors, Growth Factor _xantagonists & inhibitors
650	0	4	_aReceptors, Vascular Endothelial Growth Factor
650	0	4	_aTumor Cells, Cultured
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aGemcitabine
700	1		_aBaker, C H
700	1		_aBruns, C J
700	1		_aKillion, J J
700	1		_aEllis, L M
700	1		_aWood, J
700	1		_aFidler, I J
773	0		_tCancer biotherapy & radiopharmaceuticals _gvol. 16 _gno. 5 _gp. 359-70
856	4	0	_uhttps://doi.org/10.1089/108497801753354267 _zAvailable from publisher's website
999			_c11688624 _d11688624